M&A Deal Summary

GHO Capital Partners Acquires Sterling Pharma Solutions

On February 12, 2019, private equity firm GHO Capital Partners acquired life science company Sterling Pharma Solutions

Acquisition Highlights
  • This is GHO Capital Partners’ 7th transaction in the Life Science sector.
  • This is GHO Capital Partners’ 3rd transaction in the United Kingdom.

M&A Deal Summary
Date 2019-02-12
Target Sterling Pharma Solutions
Sector Life Science
Buyer(s) GHO Capital Partners
Deal Type Buyout (LBO, MBO, MBI)

Target

Sterling Pharma Solutions

Northumberland, United Kingdom
Sterling Pharma Solutions is a provider of API development and manufacturing, with a reputation for quality standards. Sterling delivers a full-service offering of API development and GMP manufacturing to support its customers throughout the entire product lifecycle. Sterling Pharma Solutions is based in Northumberland, United Kingdom.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

GHO Capital Partners

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2014
PE ASSETS 6.0B EUR
Size Mega
Type Sector Focused
DESCRIPTION

GHO Capital Partners is a private investment firm focused on the healthcare sector. The Firm will consider opportunities throughout Europe and seeks well-established, profitable businesses that have the potential to deliver a combination of double-digit top line growth, significant efficiency gains and international expansion. GHO Capital Partners was established in 2014 and is based in London, England.

DEAL STATS #
Overall 10 of 20
Sector (Life Science) 7 of 14
Type (Buyout (LBO, MBO, MBI)) 5 of 5
Country (United Kingdom) 3 of 3
Year (2019) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-12-20 Validant

San Francisco, California, United States

Validant is specialist consulting services to a broad range of clients across the biotech, pharma and medtech sectors. Validant was founded in 2005 and is based in San Francisco, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-07-18 Quotient Sciences

Nottingham, United Kingdom

Quotient Sciences is a provider of outsourced, early-stage drug development services to the pharmaceutical industry. Quotient Sciences has brought innovation to the pharmaceutical services sector through its unique Translational Pharmaceutics® platform, which is proven to accelerate development timelines, reduce development costs, and drive improvement in R&D productivity. Quotient Sciences is based in Nottingham, England.

Sell -
Mergr

Product

Company

Legal